EBBIL is a UK company active in the generation of dromedary camel derived single domain antibodies and VHH fragments for potential use in therapeutics and diagnostics.
Vision
To generate camel derived immune products for therapeutics and diagnostics that are affordable to all.
Mission
To combine the uniqueness of the dromedary’s immune system with advanced protein engineering to create a rapid pipeline for the treatments and diagnosis of human disease.
Our Research Activities
i. Generation of Single Domain Heavy Chain Antibodies
ii. Generation of VHH fragments antibodies
iii. Modulation of sequences of VHH fragment antibodies
iv. Scale-up of VHH fragment antibody expression